Lexaria Bioscience (LEXX) Gross Margin (2017 - 2026)
Lexaria Bioscience's Gross Margin was 100.00% in fiscal Q2 2026 (quarter ended Feb 28, 2026), unchanged from 100.00% a year earlier.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Gross Margin (2017 - 2026) Analysis & Trends
For FY2025 (ended Aug 31, 2025), Gross Margin at Lexaria Bioscience came in at 99.61%, up 0.65 percentage points from FY2024.
- Gross Margin has now increased for three consecutive fiscal years, with a five-year change of +31.18 percentage points (FY2020 to FY2025).
- In earlier fiscal years, Gross Margin was 98.96% in FY2024 (+12.89 pp), 86.07% in FY2023 (+14.20 pp), 71.87% in FY2022 (-3.87 pp) and 75.74% in FY2021 (+7.31 pp).
- Compared with a year earlier, Gross Margin was higher in two of the last seven quarters, with an average year-over-year change of +2.59 percentage points.
- The best year-over-year quarter for Gross Margin over five years was fiscal Q4 2023 (a gain of 37.11 percentage points); the worst was fiscal Q4 2021 (a drop of 45.00 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 72.78% |
| 10 | Lexaria Bioscience | 2.68 Mn | -12.58 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Feb 28, 2026 | 100.00% |
| Aug 31, 2025 | 100.00% |
| May 31, 2025 | 100.00% |
| Feb 28, 2025 | 100.00% |
| Nov 30, 2024 | 98.52% |
| Aug 31, 2024 | 100.00% |
| May 31, 2024 | 100.00% |
| Feb 29, 2024 | 100.00% |
| Nov 30, 2023 | 96.81% |
| Aug 31, 2023 | 100.00% |
| May 31, 2023 | 83.60% |
| Feb 28, 2023 | 85.23% |
| Nov 30, 2022 | 83.84% |
| Aug 31, 2022 | 62.89% |
| May 31, 2022 | 81.31% |
| Feb 28, 2022 | 79.16% |
| Nov 30, 2021 | 59.87% |
| Aug 31, 2021 | 34.53% |
| May 31, 2021 | 70.60% |
| Feb 28, 2021 | 84.08% |
API Access
Lexaria Bioscience Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();